top of page

KOL Videos

ID Week 2021
“Lenzilumab Efficacy and Safety in Hospitalized COVID-19 Subjects: Results from a Phase 3 Randomized Double-Blind Placebo-Controlled Trial”

Society of Critical Care Medicine 2022
Lenzilumab in Hospitalized Black/African-American COVID-19 Patients: LIVE-AIR Phase 3 Study Results

Mayo Clinic Proceedings
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia:
A Case-Cohort Study

bottom of page